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Background: 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG), also known as 8-hydroxy-2′-deoxyguanosine
(8-OHdG), is an oxidatively damaged nucleobases of DNA and is excreted into urine. Therefore, its urinary
level is used as a sensitive marker for oxidative stress (OS). Although it can be measured by enzyme-linked
immunosorbent assay (ELISA), its application to clinical pediatrics remains limited. Recently, a novel auto-
matic analyzer (model no. ICR-001: Techno Medica Co., Ltd., Japan) has been developed for point-of-care
testing (POCT) to measure urinary 8-oxodG. We veriﬁed the reliability of the value of urinary 8-oxodG mea-
sured by this novel analyzer and to set the age-related reference intervals.
Method: We obtained random urine samples from 100 healthy Japanese adults and 157 healthy Japanese children
aged 0–15 years. Urinary 8-oxodG was determined using two methods: competitive immunochromatography
using a novel automatic analyzer (ICR-001) and another was ELISA.
Results: Both urinary 8-oxodG and urinary creatinine measured by ICR-001 correlated well with those measured
by ELISA (rs=0.945, pb0.0001) and an enzymatic method (rs=0.988, pb0.0001). Age-related reference for 8-
oxodG corrected by creatinine were highest in the youngest subjects and decreased until adolescence, consistent
with published data by ELISA.
Conclusion: A new automatic analyzer that measures urinary 8-oxodG can be used as a POCT for the assessment of
OS levels in children.© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Oxidative stress (OS) can occur when the production of reactive
oxygen species (ROS) is accelerated or when the mechanisms in-
volved in maintaining normal reductive cellular systems are im-
paired. All types of biomolecules can be damaged by ROS, and OS is
known to be associated with aging, atherosclerosis, hypertension,
renal failure, immune alterations, neurodegeneration, reperfusion in-
jury, radiation damage, carcinogenesis, and many other degenerative
conditions in adults. Recent observations suggested that OS is impli-
cated even in childhood diseases or conditions though it is not
disease-speciﬁc [1,2]. Accordingly, it is important to objectively mea-
sure OS status in children. The direct measurement of ROS is difﬁcultygen species; 8-oxodG, 8-oxo-
deoxyguanosine.
s, Kansai Medical University,
Tel.: +81 72 804 0101x3114;
eko).
-NC-ND license.due to the short half-lives of these species, and thus OS biomarkers
are commonly measured using stable products of oxidative processes.
8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) [3], also known
as 8-hydroxy-2′-deoxyguanosine (8-OHdG), is a product of an
oxidatively modiﬁed guanine base excreted into urine and currently
used as one of the sensitive biomarkers for oxidative cellular damage.
Therefore, it has been postulated that it is a useful biomarker for
evaluating the cardiovascular risk factors and inﬂammatory status in
hypertensive patients [4,5], for identifying persons at risk of
developing cancer [6], for early prediction of lifestyle related-
disease risks [7,8] and for assessing the environmental conditions
including sunlight exposure that are expected to have a serious
long-term impact on the health status in adults [9,10]. Despite
growing interest in urinary 8-oxodG as a sensitive OS biomarker
in sick children as well as in adults [1,2], its use is hindered in clin-
ical settings because the current assays depend on a complicated
methodology to measure 8-oxodG, such as an enzyme-linked im-
munosorbent assay (ELISA) [7,9,11–16]. Furthermore, limited infor-
mation exists regarding age and sex related reference intervals
[15,16] in healthy children. Therefore, an easy, rapid, sensitive
and speciﬁc assay, i.e., point-of-care testing (POCT) to measure
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assessment of OS levels in children.2. Materials and methods
2.1. Subjects
We obtained random urine samples from 100 healthy adult volun-
teers. Only Japanese volunteers were enrolled in the study to avoid
the effect of racial difference reported previously [17]. These samples
were used to perform regression analysis of the concentrations of uri-
nary 8-oxodG measured by the ELISA assay and to compare them to
concentrations obtained by an automatic analyzer (ICR-001). Further-
more, they were also used to set adult reference intervals of urinary
8-oxodG corrected by creatinine (ng/mg creatinine). The median
age of the healthy adult volunteers was 33.5 y (range: 22–62 y’”).
Urine samples were also obtained from 157 healthy Japanese chil-
dren consisting of 24 neonates and 95 toddlers and 38 children: urine
from the 24 neonates was collected at Izumi-Ohtsu Municipal Hospi-
tal, Izumi-Ohtsu City, Osaka where they were born at and that from
toddlers and children was collected at Nabari City, Mie, Japan at the
time of their regularly scheduled clinical checkup. Subjects included
83 males and 74 females, and no signiﬁcant difference in age was
found between males (median 3.53 y, range 0.00–15.10 y) and
females (median 3.52 y, range 0.00-14.94 y) by the two-tailed
Welch's t-test (p=0.93).
No subjects were suffered from acute illness or chronic conditions
at the time of study and were taking any medication at the time of
urine collection. Study subjects had a sufﬁcient dietary intake of nu-
trients and were considered to be representative of healthy young
populations of Japan.
The study protocol was approved by the regional ethical commit-
tee of Izumi-Ohtsu Municipal Hospital and Nabari Municipal Hospital.
The nature and purpose of the study were explained to the subjects
and their parents. Informed consent was obtained from individuals
or parents prior to enrollment.2.2. Sample storage
Random urine samples were obtained from each subject. The sam-
ples were centrifuged, and the supernatants were stored at −20 °C
until analysis. The examiners were blinded to the clinical and labora-
tory results.A
B
A
b. Creatinine test strip
A B
R
a. 8-OHdG test strip
Fig. 1. Principle of 8-oxodG measurement based on competitive immunochromatography u
D: control zone, E: absorption pad; b: Creatinine test strip, A: alkaline pad, B: picric acid pa3. Methods
3.1. 8-oxodG assay
The concentration of 8-oxodG was determined in all samples using
2 methods: competitive immunochromatography using a newly devel-
oped automatic analyzer (ICR-001) and another was ELISA.3.1.1. Automatic assay using model no. ICR-001
ICR–001 (Techno Medica Co., Ltd. Yokohama, Japan) is a urinary
oxidative stress marker measurement system consisting of a detector,
an external computer and single use sensor cards. This device is
unique because it is designed exclusively for the measurement of 8-
oxodG and creatinine. Test strips for 8-oxodG and creatinine are em-
bedded in the sensor card (Fig. 1a, b). Measurement of 8-oxodG is
performed using competitive immunochromatography. The urine
sample is placed dropwise onto a sample pad (Fig. 1a, A) and then mi-
grates to a conjugate pad that includes antibodies conjugated to gold
particles (Fig. 1a, B), where the immuno-reaction between 8-oxodG
and the conjugate begins. The sample then travels to the capture
zone (Fig. 1a, C) and excess unbound conjugate binds to the
immobilized 8-oxodG (Fig. 2a, R1) while the bound conjugates are
blocked. Finally, the bound conjugate binds to the antibodies
(Fig. 1a, R2) in the control zone (D). As the intensity of the colored
lines R1 and R2 is dependent on 8-oxodG concentration, the rate of
color change detected by a built-in image detector is converted to
the concentration of 8-oxodG using the standard curve. The internal
detector equipped with CMOS (complementary metal-oxide semi-
conductor) camera and white light emitting diode (LED) illuminant
reads only green color at the wavelength of 500–600 nm.
The collected urine sample is diluted 2-fold with distilled water
and 100 μl of the diluted urine is placed into each inlet. Reaction re-
sults are observed in each measurement window after 5 min. The de-
tector receives the reaction results from each window and transfers it
to the computer. The computer is used to operate the detector, per-
form image processing and to display the results.
Monoclonal antibody against 8-oxodG was obtained from hybridoma
developed by rat lymph node cells and mouse myeloma cells (cell strain
1B1: FERMAP-20122, publication number: 2006–056859). This antibody
is conﬁrmed not to react with guanosine, 2′-deoxyguanosine, 2′-
deoxyadenosine, 2′-deoxyinosine, 8-bromo-2′-deoxyguanosine while
less than 10% of cross reactivity with 8-hydroxyguanosine is observed.
Both the coefﬁcient of variations (CV) in intra-assay and inter-assay
were b13%. Limit of detection (LOD) are 0.1 ng/ml as an analyticalC D
E
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sing ICR-001. a: 8‐oxodG test strip, A: sample pad, B: conjugate pad, C: capture zone,
d, C: standard color 1, D: standard color 2.
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Fig. 2. Relationship between urinary 8-oxodG values obtained by the ICR-001 and
Enzyme-Linked Immunosorbent Assay (ELISA). Linear regression analysis produced
the following formula: 8‐oxodG by ICR‐001=0.85×(8‐oxodG by ELISA)+3.23 (rs=
0.945, pb0.00001).
1824 K. Kaneko et al. / Clinica Chimica Acta 413 (2012) 1822–1826sensitivity and 0.5 ng/ml as a functional sensitivity. Recovery percentage
is reported to be >80%. Both the CV and the recovery percentage were
comparable to those determined by the ELISA assay [18].3.1.2. ELISA assay
The ELISA assay was performed using a commercially available kit
(New 8-oxodG Check ELISA: Japan Institute for the Control of Aging,
Nikken Seil Co., Ltd. Shizuoka, Japan), which has been widely used
for the detection of 8-oxodG. The assay was performed according to
manufacturer's instructions. Brieﬂy, the urine samples were diluted
with Tris–HCl buffer (pH 7.4) prior to detection. Tolerance to pH
change ranged from pH 5 to pH 10 in human urine. Assay plates
were read at 450 nm with a microplate reader. The detection limits
for 8-oxodG was 0.5-200 ng/ml.300
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3.2.1. Automatic assay using model no. ICR-001
We adapted the Jaffe method to measure creatinine levels in
human urine. As the urine sample is dropped on the sample pad
(Fig. 2b, A), it blends with a strong alkaline material embedded in
the pad. Then, the mixed sample migrates to a picric acid pad
(Fig. 2b, B) where the color change reaction occurs. Finally, the
color change reaction is compared to standard colors 1 and 2, and
the result is converted into concentration through image processing.
It is conﬁrmed that both human serum albumin b1000 mg/dl and
glucose less than 100,000 mg/dl do not interfere the assay. The LOD
are 2 mg/dl as an analytical sensitivity and 5 mg/dl as a functional
sensitivity.0
100
200
0 100 200 300 400 500 600 700
I
Data by enzymatic method (mg/dL)
Fig. 3. Relationship between urinary creatinine values obtained by the ICR-001 and en-
zymatic assay. Linear regression analysis produced the following formula: creatinine by
ICR‐001=1.06×(creatinine by enzymatic assay)−5.81 (rs=0.988, pb0.00001).3.2.2. Enzymatic method
The enzymatic creatinine assay was run on the AU 5421 automatic
analytical system (Olympus Co. Ltd., Tokyo, Japan). This assay is based
on the enzymatic conversion of creatinine to sarcosine, which in turn
produces hydrogen peroxide via sarcosine oxidase. Hydrogen perox-
ide reacts with chromogen to produce quinone dye by peroxidase.
The reaction is monitored by colorimetric analysis, and the rate is
proportional to the creatinine concentration.3.3. Statistics
The values of urinary 8-oxodG and creatinine did not follow a nor-
mal distribution, and thus all data were presented as median and
range. Both quartiles and percentiles for 2.5, 5. 10, 90, 95, 97.5 were
also determined as appropriate. Correlations between variables
were assessed by Spearman rank correlation tests and rs denoted its
coefﬁcient of correlation. Statistical signiﬁcance was inferred for
pb0.05.
4. Results
4.1. Reliability of urinary 8-oxodG and creatinine concentrationsmeasured
by ICR-001.
The median level and range of urinary 8-oxodGmeasured by com-
petitive immunochromatography (ICR-001) and by ELISA were as
follows: ICR-001, median 20.0 ng/ml, range 2.60-69.4 ng/ml; ELISA,
median 19.7 ng/ml, range 1.70-69.0 ng/ml. As shown in Fig. 2, values
of urinary 8-oxodGmeasured by ICR-001 correlatedwellwith thosemea-
sured by ELISA (rs=0.945, pb0.0001). Linear regression analysis pro-
duced the following formula: 8-oxodG by ICR-001=0.85×(8-oxodG by
ELISA)+3.23.
The median levels and ranges of urinary creatinine measured
by the Jaffe method (ICR-001) and the enzymatic method were as
follows: ICR-001, median 225.5 mg/dl, range 17.2-598.0 mg/dl; enzy-
matic method, median 223.5 mg/dl, range 21.0-573.7 mg/dl. As
shown in Fig. 3, values of urinary creatinine measured by ICR-001
correlated well with those measured by enzymatic method (rs=
0.988, pb0.0001). Linear regression analysis produced the following
formula: creatinine by ICR-001=1.06×(creatinine by enzymatic
assay)−5.81.
As a result, urinary levels of 8-oxodG corrected by creatinine of
healthy adult Japaneseweremedian 9.93 ng/mg creatinine [interquartile
range: 8.46-11.92] which were comparable to those determined by the
ELISA [7,9].
4.2. Age and sex related reference intervals for urinary 8-oxodG as
measured by the automatic analyzer
Given the strong linear correlation between ICR-001 and the stan-
dard assays, we attempted to determine the age and sex related refer-
ence intervals of children for urinary 8-oxodG corrected by creatinine
by ICR-001.
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urinary 8-oxodG corrected by creatinine (ng/mg creatinine): males,
median 15.8, range 4.30-111.2; females, median 16.7, range 4.20-
90.4.
The subjects were then classiﬁed into the four groups to assess the
inﬂuence of age as shown in Table 1: neonates (n=24), 1–4 years
(n=95), 5–9 years (n=19), and 10–15 years (n=19). To compare
the age related reference intervals for children with adult one, the
data obtained by the correlation assay were used (n=100).
The results are presented in Fig. 4 and demonstrate a signiﬁcant
inverse correlation between the level of urinary 8-oxodG corrected
by creatinine and the age of the subjects (rs=−0.36, p b0.0001),
i.e., younger children exhibit higher urinary 8-oxodG concentrations.8-
ox
o 1
Neonates 1y - 4y 5y - 9y 10y - 15y Adults
Fig. 4. Age-related urinary 8-oxodG corrected by creatinine using ICR-001.
5. Discussion
ROS are primarily generated in mitochondria as byproducts of cel-
lular metabolism. Physiological amounts of ROS are a cellular require-
ment for signaling pathways and in the defense against invading
pathogens; however, cells possess many antioxidant systems for
scavenging or otherwise eliminating ROS to prevent cellular damage.
OS occurs when ROS production is accelerated or when the mecha-
nisms involved in maintaining the normal reductive cellular systems
are impaired. As all types of biomolecules can be damaged by ROS, OS
is known to be associated with aging, atherosclerosis, hypertension,
renal failure, immune alterations, neurodegeneration, reperfusion inju-
ry, radiation damage, carcinogenesis, and many other degenerative
conditions in adults. Although OS is not disease-speciﬁc, recent obser-
vations suggest that OS is implicated even in various childhood diseases
or conditions [1,2]. These diseases include septic shock [19], meningitis
[20], bronchial asthma [21], diabetesmellitus [22], leukemia [23], mito-
chondrial disorder [24], epilepsy [25], autism [26], Down syndrome
[27], and other diseases. OS also contribute to cellular DNA damage in-
duced by exposure to radiation [28] or certain drugs such as valproate
[29]. We have also studied the involvement of OS in certain diseases
in childhood, such as idiopathic nephrotic syndrome [30], Kawasaki dis-
ease [31], or renal hypouricemia [32].
Oxidative tissue injury from pathological conditions may have
more serious consequences in children than in adults due to the
need for subsequent tissue growth to match somatic growth and to
maintain survival [16]. Therefore, preventing oxidative damage may
be important, particularly in young people. Furthermore, as the use
of antioxidants has presented new therapeutic perspectives for dis-
eases related to enhancement of OS, it becomes important to assess
objectively OS status in children.
Despite increasing attention, OS status in healthy children has been
incompletely characterized and the establishment of normal values for
OS biomarkers remains limited in the literature. Direct measurement
of ROS is difﬁcult due to the short half-life of these species and thus,
OS biomarkers are often measured using stable substances producedTable 1
Age-related changes in urinary 8-oxodG as determined by ICR-001 (ng/mg creatinine).
Neonates 1–4 y 5–9 y 10–15 y Adults
n 24 95 19 19 100
Minimum 4.20 7.30 5.70 4.30 5.32
2.5 percentile 6.04 9.11 5.75 4.75 5.87
5 percentile 7.69 9.78 5.79 5.20 6.42
10 percentile 13.60 11.6 6.70 6.40 7.10
1st quartile 15.33 13.35 8.75 6.95 8.46
Median 20.25 16.90 11.40 9.90 9.93
3rd quartile 26.90 23.05 20.25 14.10 11.92
90 percentile 28.50 31.40 25.00 27.00 15.70
95 percentile 37.69 35.12 65.20 43.12 18.12
97.5 percentile 40.03 45.85 77.80 45.91 21.98
Maximum 42.90 111.20 90.40 48.70 25.63as a result of the oxidative processes. These include malondialdehyde-
lysine, acrolein-lysine, F2-isoprostane, 8-oxodG, pentosidine, nitrite/
nitrate, nitrotyrosine, and others [1,2]. It is also important to collect
samples non-invasively in pediatric cohorts. Urine collection is non-
invasive and is therefore particularly easy to perform in children. In
this regard, urinary 8-oxodG, a product of an oxidatively modiﬁed
guanine base excreted into urine, is an ideal candidate as a sensitive bio-
marker for oxidative cellular damage in children. In adults, urinary 8-
oxodG has been already known to be a useful biomarker for evaluating
the cardiovascular risk factors and inﬂammatory status in hypertensive
patients [4,5], for identifying persons at risk of developing cancer [6], for
early prediction of lifestyle related-disease risks [7,8] and for assessing
the environmental conditions including sunlight exposure that are
expected to have a serious long-term impact on health in adults [9,10].
Therefore, we believe that measuring serial changes of urinary 8-
oxodG is of great worth in diverse clinical pediatric settings, such as
evaluating harmful effects of radiation exposure or cytotoxic drugs
on child health, monitoring disease activity, predicting complications
of the diseases or assessing the therapeutic responses. However, the
current assay used to measure urinary 8-oxodG (ELISA) in the clinical
setting is relatively complex and remains primarily a laboratory re-
search tool.
A recently developed automatic analyzer (ICR-001) to measure
urinary 8-oxodG has been developed for POCT and has been commer-
cially available in Japan since 2010. Sample-to-answer time is only
5 minutes for simultaneous detection of urinary creatinine and 8-
oxodG concentrations. The analyzer can be used in routine clinical
settings, such as an outpatient clinic (use conditions: temperature
18–30 °C, humidity 30%–80%) and is portable (width 150 mm,
depth 160 mm, height 170 mm, weight 2.8 kg).
In the present study, we veriﬁed the reliability of this new device
in measuring urinary 8-oxodG concentration by comparing the re-
sults of this device with those by the ELISA, and also determined
sex- and age-related changes in healthy children and adults. First,
the results demonstrate that the values of both urinary 8-oxodG and
creatinine obtained by the ICR-001 correlated well with those mea-
sured both by ELISA and the urinary levels of 8-oxodG corrected by
creatinine of healthy adult Japanese were comparable to those of
the published ones determined by the ELISA [7,9]. Accordingly, the
value of urinary 8-oxodG corrected by creatinine determined by
ICR-001 was conﬁrmed to have comparable reliability to the standard
method. Second, we determined sex- and age-related changes in
healthy children which demonstrated that the values of urinary 8-
oxodG corrected by creatinine were highest in the youngest subjects
and decreased through adolescence to reach a plateau, showing a sig-
niﬁcant inverse correlation with age. Meanwhile, there was no signif-
icant difference in urinary 8-oxodG concentrations between healthy
males and females. The results of urinary 8-oxodG measurements in
1826 K. Kaneko et al. / Clinica Chimica Acta 413 (2012) 1822–1826children are consistent with previously published data in children
[1,16] that were determined using the ELISA. Furthermore, the
presented age-related reference intervals appears to be accurate
enough for clinical application as we recently reported that the chil-
dren with heart diseases receiving cardiac catheterization revealed
approximately 4-fold increase in urinary 8-oxodG after radiation ex-
posure and that 8 of 14 children showed the extremely high levels
over 90 percentile of the reference intervals after radiation exposure
[33].
The mechanisms underlying higher levels of urinary 8-oxodG in
younger subjects remain unanswered. Children experiencing rapid
growth and sustained immune activation are prone to be exposed
to high concentrations of ROS and are therefore more vulnerable to
oxidation of lipids, proteins, and DNA, which would result in higher
urinary excretion of 8-oxodG [1,14].
6. Conclusion
Urinary 8-oxodG can be measured by a competitive immuno-
chromatography in 5 min. using a novel automatic analytical system,
ICR-001. Age-related reference intervals for urinary 8-oxodG
corrected by creatinine measured with this device exhibit an inverse
correlation with age and no correlation to gender and are consistent
with results reported by the gold standard method. These results sug-
gest that a newly developed automatic analyzer to measure urinary
8-oxodG can be used as an easy, rapid, sensitive and speciﬁc POCT
for the assessment of OS levels in children.
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